The Aesthetic Channel

To view this email as a web page, click here.

February 8, 2019

Honoring a gifted cosmetic dermatologist and mentor

With great regret we acknowledge the passing of Vic A. Narurkar, M.D., F.A.A.D., an internationally known, board certified dermatologist and dermatologic surgeon from San Francisco, Calif. As a renowned leader in cosmetic dermatology, Dr. Narurkar generously gave back to the medical community in numerous ways – as a leader, educator, researcher, author, developer of new treatment protocols and techniques, and more.

New injectable neurotoxin receives FDA clearance

The U.S. aesthetic facial injectables market is set to expand in 2019 with the FDA approval of Jeuveau (prabotulinumtoxinA-xvfs), an injectable neurotoxin that is structurally similar to Botox Cosmetic. Set to launch in Spring 2019, Jeuveau is cleared for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and / or procerus muscle activity in adults.

Read more

Clinical results for RT002 neurotoxin confirm longer duration of effect

Positive study results boost confidence in RT002 as a safe and effective longer-lasting neurotoxin treatment for moderate to severe glabellar lines in adults. Based on these study findings, Revance expects U.S. FDA approval in 2019.

Read more

The Cosmetic Professional’s Guide to Patient Financing

Would you like to grow your revenue while saving thousands in provider fees? Download the Ultimate Guide to Patient Financing to learn how! Read more.

We want to hear from you!

Have comments or questions about the eNewsletter? Contact us!
The Aesthetic Guide and The Aesthetic Channel editor, Erin Velardo at [email protected]

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.